{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:07:04Z","timestamp":1789052824844,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 (GLP-1), gastric inhibitory peptide (GIP), glucagon, and glicentin are gastrointestinal hormones derived from proglucagon that play crucial roles in regulating appetite and glucose homeostasis. These hormones have been examined during the acute state of anorexia nervosa (AN), with our previous study showing elevated GIP levels in the acute state which normalized following short-term weight restoration. GLP-1 and glicentin concentrations remain unchanged in the acute state, but decrease after short-term weight restoration. However, few studies have investigated whether these alterations are more than mere consequences of the severe underweight, whether they persist after long-term recovery, and whether they could therefore be considered potential trait markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the current study, we assessed fasting serum concentrations of GLP-1, GIP, glucagon, and glicentin in 80 female individuals who had long-term recovered from AN and 100 healthy female controls. For group comparisons, a subset of 70 controls was pairwise age-matched to the recovered patients. Participants were further stratified by oral contraceptive (OC) use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant differences in hormone concentrations, confirmed by Bayesian statistics, were observed between controls and recovered patients, regardless of OC use, except for glucagon levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that alterations in gut-secreted hormones associated with glucose homeostasis during the acute, malnourished phase of AN reflect state-dependent changes that do not persist after recovery. OC use in former patients with AN does not affect the concentration of these hormones during recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40337-026-01763-y","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:46:22Z","timestamp":1789044382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fasting gut hormone levels following long-term recovery from Anorexia Nervosa: A cross-sectional study"],"prefix":"10.1186","volume":"14","author":[{"given":"Theresa","family":"Kolb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike Ingrid","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"F\u00f6rster Ribet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Ohme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Carlotta","family":"Schlolaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Adam","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne Lee","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine Maria","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Perakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [Internet]. Fifth Edition, American Psychiatric Association. 2013 [zitiert 11. Juni 2025]. Verf\u00fcgbar unter: https:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"14","key":"1763_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1803175","volume":"382","author":"JE Mitchell","year":"2020","unstructured":"Mitchell JE, Peterson CB, Solomon CG, Herausgeber. N Engl J Med 2 April. 2020;382(14):1343\u201351. https:\/\/doi.org\/10.1056\/NEJMcp1803175.","journal-title":"N Engl J Med 2 April"},{"issue":"12","key":"1763_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S2215-0366(15)00356-9","volume":"2","author":"S Zipfel","year":"2015","unstructured":"Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry Dezember. 2015;2(12):1099\u2013111. https:\/\/doi.org\/10.1016\/S2215-0366(15)00356-9.","journal-title":"Lancet Psychiatry Dezember"},{"issue":"8","key":"1763_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","volume":"159","author":"HC Steinhausen","year":"2002","unstructured":"Steinhausen HC. The Outcome of Anorexia Nervosa in the 20th Century. Am J Psychiatry August. 2002;159(8):1284\u201393. https:\/\/doi.org\/10.1176\/appi.ajp.159.8.1284.","journal-title":"Am J Psychiatry August"},{"issue":"3","key":"1763_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsych.2017.08.011","volume":"83","author":"JA King","year":"2018","unstructured":"King JA, Frank GKW, Thompson PM, Ehrlich S. Structural Neuroimaging of Anorexia Nervosa: Future Directions in the Quest for Mechanisms Underlying Dynamic Alterations. Biol Psychiatry Februar. 2018;83(3):224\u201334. https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.011.","journal-title":"Biol Psychiatry Februar"},{"issue":"1","key":"1763_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40337-016-0118-y","volume":"4","author":"TS Fuglset","year":"2016","unstructured":"Fuglset TS, Landr\u00f8 NI, Reas DL, R\u00f8 \u00d8. Functional brain alterations in anorexia nervosa: a scoping review. J Eat Disord Dezember. 2016;4(1):32. https:\/\/doi.org\/10.1186\/s40337-016-0118-y.","journal-title":"J Eat Disord Dezember"},{"key":"1763_CR7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20548","author":"K Jada","year":"2021","unstructured":"Jada K, Djossi SK, Khedr A, Neupane B, Proskuriakova E, Mostafa JA. The Pathophysiology of Anorexia Nervosa in Hypothalamic Endocrine Function and Bone Metabolism. Cureus 20 Dezember. 2021. https:\/\/doi.org\/10.7759\/cureus.20548.","journal-title":"Cureus 20 Dezember"},{"key":"1763_CR8","doi-asserted-by":"publisher","unstructured":"St\u00f8ving RK, Hangaard J, Hagen C. Update on Endocrine Disturbances in Anorexia Nervosa. J Pediatr Endocrinol Metab Januar. 2001;14(5). https:\/\/doi.org\/10.1515\/JPEM.2001.14.5.459.","DOI":"10.1515\/JPEM.2001.14.5.459"},{"issue":"1","key":"1763_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.mp.4001909","volume":"12","author":"J Hebebrand","year":"2007","unstructured":"Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 1 Januar. 2007;12(1):23\u201335. https:\/\/doi.org\/10.1038\/sj.mp.4001909.","journal-title":"Mol Psychiatry 1 Januar"},{"key":"1763_CR10","doi-asserted-by":"publisher","unstructured":"M\u00e9quinion M, Langlet F, Zgheib S, Dickson S, Dehouck B, Chauveau C. u. a. Ghrelin: Central and Peripheral Implications in Anorexia Nervosa. Front Endocrinol. 2013;4. https:\/\/doi.org\/10.3389\/fendo.2013.00015.","DOI":"10.3389\/fendo.2013.00015"},{"issue":"7","key":"1763_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/ijms19072117","volume":"19","author":"MA Schalla","year":"2018","unstructured":"Schalla MA, Stengel A. The Role of Ghrelin in Anorexia Nervosa. Int J Mol Sci 20 Juli. 2018;19(7):2117. https:\/\/doi.org\/10.3390\/ijms19072117.","journal-title":"Int J Mol Sci 20 Juli"},{"issue":"2","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/nu13020709","volume":"13","author":"M Seidel","year":"2021","unstructured":"Seidel M, Markmann Jensen S, Healy D, Dureja A, Watson HJ, Holst B. u. a. A Systematic Review and Meta-Analysis Finds Increased Blood Levels of All Forms of Ghrelin in Both Restricting and Binge-Eating\/Purging Subtypes of Anorexia Nervosa. Nutrients 23 Februar. 2021;13(2):709. https:\/\/doi.org\/10.3390\/nu13020709","journal-title":"Nutrients 23 Februar"},{"issue":"10","key":"1763_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia Oktober. 2023;66(10):1765\u201379. https:\/\/doi.org\/10.1007\/s00125-023-05906-7.","journal-title":"Diabetologia Oktober"},{"issue":"4","key":"1763_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The Physiology of Glucagon-like Peptide 1. Physiol Rev Oktober. 2007;87(4):1409\u201339. https:\/\/doi.org\/10.1152\/physrev.00034.2006.","journal-title":"Physiol Rev Oktober"},{"issue":"10","key":"1763_CR15","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1172\/JCI78371","volume":"124","author":"LL Baggio","year":"2014","unstructured":"Baggio LL, Drucker DJ. Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight. J Clin Invest Oktober. 2014;124(10):4223\u20136. https:\/\/doi.org\/10.1172\/JCI78371","journal-title":"J Clin Invest Oktober"},{"issue":"3","key":"1763_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1900\/RDS.2011.8.418","volume":"8","author":"C Cabou","year":"2011","unstructured":"Cabou C, Burcelin R. GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud RDS. 2011;8(3):418\u201331. https:\/\/doi.org\/10.1900\/RDS.2011.8.418","journal-title":"Rev Diabet Stud RDS"},{"key":"1763_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2015.02.017","volume":"418","author":"D Sandoval","year":"2015","unstructured":"Sandoval D, Sisley SR. Brain GLP-1 and insulin sensitivity. Mol Cell Endocrinol Dezember. 2015;418:27\u201332. https:\/\/doi.org\/10.1016\/j.mce.2015.02.017.","journal-title":"Mol Cell Endocrinol Dezember"},{"issue":"5","key":"1763_CR18","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/dom.14315","volume":"23","author":"N Perakakis","year":"2021","unstructured":"Perakakis N, Farr OM, Mantzoros CS. Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study. Diabetes Obes Metab Mai. 2021;23(5):1202\u20137. https:\/\/doi.org\/10.1111\/dom.14315","journal-title":"Diabetes Obes Metab Mai"},{"issue":"8","key":"1763_CR19","doi-asserted-by":"publisher","first-page":"e3003","DOI":"10.1210\/clinem\/dgaa329","volume":"105","author":"N Perakakis","year":"2020","unstructured":"Perakakis N, Mantzoros CS. The Role of Glicentin and Oxyntomodulin in Human Metabolism: New Evidence and New Directions. J Clin Endocrinol Metab 1 August. 2020;105(8):e3003\u20135. https:\/\/doi.org\/10.1210\/clinem\/dgaa329.","journal-title":"J Clin Endocrinol Metab 1 August"},{"key":"1763_CR20","doi-asserted-by":"publisher","first-page":"8352957","DOI":"10.1155\/2016\/8352957","volume":"2016","author":"NJ Wewer Albrechtsen","year":"2016","unstructured":"Wewer Albrechtsen NJ, Veedfald S, Plamboeck A, Deacon CF, Hartmann B, Knop FK. u. a. Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion. J Diabetes Res. 2016;2016:8352957. https:\/\/doi.org\/10.1155\/2016\/8352957","journal-title":"J Diabetes Res"},{"issue":"2\/3","key":"1763_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0022-3956(85)90019-6","volume":"19","author":"JT Alderdice","year":"1985","unstructured":"Alderdice JT, Dinsmore WW, Buchanan KD, Adams C. Gastrointestinal Hormones in Anorexia Nervosa. J Psychiatr Res. 1985;19(2\/3):207\u201313.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"1763_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1530\/EJE-13-0941","volume":"170","author":"MJ Bak","year":"2014","unstructured":"Bak MJ, Albrechtsen NW, Pedersen J, Hartmann B, Christensen M, Vilsb\u00f8ll T. u. a. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol April. 2014;170(4):529\u201338. https:\/\/doi.org\/10.1530\/EJE-13-0941","journal-title":"Eur J Endocrinol April"},{"key":"1763_CR23","doi-asserted-by":"publisher","unstructured":"Deacon CF, Holst JJ. August. Immunoassays for the incretin hormones GIP and GLP-1. Best Pract Res Clin Endocrinol Metab. 2009;23(4):425\u201332. https:\/\/doi.org\/10.1016\/j.beem.2009.03.006","DOI":"10.1016\/j.beem.2009.03.006"},{"issue":"4","key":"1763_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/1098-108X(198511)4:4<597::AID-EAT2260040418>3.0.CO;2-L","volume":"4","author":"KN Dixon","year":"1985","unstructured":"Dixon KN, O\u2019Dorisio TM, Zipf W, Cataland S. Gastric inhibitory polypeptide (GIP) in anorexia nervosa. Int J Eat Disord November. 1985;4(4):597\u2013604.","journal-title":"Int J Eat Disord November"},{"issue":"4","key":"1763_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ajcn\/85.4.967","volume":"85","author":"N Germain","year":"2007","unstructured":"Germain N, Galusca B, Le Roux CW, Bossu C, Ghatei MA, Lang F. u. a. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr April. 2007;85(4):967\u201371. https:\/\/doi.org\/10.1093\/ajcn\/85.4.967.","journal-title":"Am J Clin Nutr April"},{"issue":"4","key":"1763_CR26","doi-asserted-by":"publisher","first-page":"E565","DOI":"10.1152\/ajpendo.00149.2018","volume":"315","author":"GA Heruc","year":"2018","unstructured":"Heruc GA, Little TJ, Kohn MR, Madden S, Clarke SD, Horowitz M. u. a. Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa. Am J Physiol-Endocrinol Metab 1 Oktober. 2018;315(4):E565\u201373. https:\/\/doi.org\/10.1152\/ajpendo.00149.2018.","journal-title":"Am J Physiol-Endocrinol Metab 1 Oktober"},{"issue":"2","key":"1763_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ajcn\/47.2.239","volume":"47","author":"M Kumai","year":"1988","unstructured":"Kumai M, Tamai H, Fujii S, Nakagawa T, Aoki TT. Glucagon secretion in anorexia nervosa. Am J Clin Nutr Februar. 1988;47(2):239\u201342. https:\/\/doi.org\/10.1093\/ajcn\/47.2.239.","journal-title":"Am J Clin Nutr Februar"},{"issue":"4","key":"1763_CR28","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1210\/jc.2004-1251","volume":"90","author":"S Stock","year":"2005","unstructured":"Stock S, Leichner P, Wong ACK, Ghatei MA, Kieffer TJ, Bloom SR, Ghrelin ua, Peptide YY, et al. Glucose-Dependent Insulinotropic Polypeptide, and Hunger Responses to a Mixed Meal in Anorexic, Obese, and Control Female Adolescents. J Clin Endocrinol Metab 1 April. 2005;90(4):2161\u20138. https:\/\/doi.org\/10.1210\/jc.2004-1251.","journal-title":"J Clin Endocrinol Metab 1 April"},{"issue":"2","key":"1763_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/s-2002-20519","volume":"34","author":"P Tomasik","year":"2002","unstructured":"Tomasik P, Sztefko K, Malek A. GLP-1 as a Satiety Factor in Children with Eating Disorders. Horm Metab Res Februar. 2002;34(2):77\u201380. https:\/\/doi.org\/10.1055\/s-2002-20519.","journal-title":"Horm Metab Res Februar"},{"key":"1763_CR30","doi-asserted-by":"publisher","unstructured":"Tomasik PJ, Sztefko K, Starzyk J, Cholecystokinin. Glucose Dependent Insulinotropic Peptide and Glucagon-like Peptide 1 Secretion in Children with Anorexia Nervosa and Simple Obesity. J Pediatr Endocrinol Metab Januar. 2004;17(12). https:\/\/doi.org\/10.1515\/JPEM.2004.17.12.1623.","DOI":"10.1515\/JPEM.2004.17.12.1623"},{"issue":"4","key":"1763_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.psyneuen.2004.10.003","volume":"30","author":"PJ Tomasik","year":"2005","unstructured":"Tomasik PJ, Sztefko K, Starzyk J, Rogatko I, Szafran Z. Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology Mai. 2005;30(4):364\u201372. https:\/\/doi.org\/10.1016\/j.psyneuen.2004.10.003.","journal-title":"Psychoneuroendocrinology Mai"},{"key":"1763_CR32","doi-asserted-by":"publisher","first-page":"111576","DOI":"10.1016\/j.pnpbp.2025.111576","volume":"144","author":"T Kolb","year":"2026","unstructured":"Kolb T, Licht L, Tam FI, Stender EM, Ohme M, Borsini A. u. a. Circulating levels of gut hormones in anorexia nervosa before and after short-term weight restoration. Prog Neuropsychopharmacol Biol Psychiatry Januar. 2026;144:111576. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111576.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry Januar"},{"issue":"8","key":"1763_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrn2682","volume":"10","author":"WH Kaye","year":"2009","unstructured":"Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci August. 2009;10(8):573\u201384. https:\/\/doi.org\/10.1038\/nrn2682.","journal-title":"Nat Rev Neurosci August"},{"issue":"02","key":"1763_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1055\/a-1259-1609","volume":"81","author":"S Franik","year":"2021","unstructured":"Franik S, Bauersachs R, Beyer-Westendorf J, Buchholz T, B\u00fchling K, Diener HC. u. a. Hormonal Contraception. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry Number 015\/015, January 2020. Geburtshilfe Frauenheilkd Februar. 2021;81(02):152\u201382. https:\/\/doi.org\/10.1055\/a-1259-1609.","journal-title":"Geburtshilfe Frauenheilkd Februar"},{"issue":"1","key":"1763_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/AOG.0b013e318202ac23","volume":"117","author":"AB Berenson","year":"2011","unstructured":"Berenson AB, Van Den Berg P, Williams KJ, Rahman M. Effect of Injectable and Oral Contraceptives on Glucose and Insulin Levels. Obstet Gynecol Januar. 2011;117(1):41\u20137. https:\/\/doi.org\/10.1097\/AOG.0b013e318202ac23.","journal-title":"Obstet Gynecol Januar"},{"issue":"1","key":"1763_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1210\/jcem.74.1.1530790","volume":"74","author":"IF Godsland","year":"1992","unstructured":"Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab Januar. 1992;74(1):64\u201370. https:\/\/doi.org\/10.1210\/jcem.74.1.1530790.","journal-title":"J Clin Endocrinol Metab Januar"},{"issue":"6","key":"1763_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/0002-9378(83)90437-4","volume":"147","author":"VV Gossain","year":"1983","unstructured":"Gossain VV, Sherma NK, Michelakis AM, Rovner DR. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. Am J Obstet Gynecol November. 1983;147(6):618\u201323. https:\/\/doi.org\/10.1016\/0002-9378(83)90437-4.","journal-title":"Am J Obstet Gynecol November"},{"issue":"4","key":"1763_CR38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0002-9378(12)90408-1","volume":"167","author":"RM Krauss","year":"1992","unstructured":"Krauss RM, Burkman RT. The metabolic impact of oral contraceptives. Am J Obstet Gynecol Oktober. 1992;167(4):1177\u201384. https:\/\/doi.org\/10.1016\/S0002-9378(12)90408-1.","journal-title":"Am J Obstet Gynecol Oktober"},{"issue":"2","key":"1763_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1067\/mob.2000.105909","volume":"183","author":"RJ Troisi","year":"2000","unstructured":"Troisi RJ, Cowie CC, Harris MI. Oral contraceptive use and glucose metabolism in a national sample of women in the United States. Am J Obstet Gynecol August. 2000;183(2):389\u201395. https:\/\/doi.org\/10.1067\/mob.2000.105909.","journal-title":"Am J Obstet Gynecol August"},{"key":"1763_CR40","doi-asserted-by":"crossref","unstructured":"Fichter M, Quadflieg N. Das Strukturierte Interview f\u00fcr Anorektische und Bulimische Ess-St\u00f6rungen nach DSM-IV und ICD-10 zur Expertenbeurteilung (SIAB-EX) und dazugeh\u00f6riger Fragebogen zur Selbsteinsch\u00e4tzung. SIAB-S; 2001.","DOI":"10.1159\/000056675"},{"issue":"Suppl 20","key":"1763_CR41","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. u. a. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333. quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1763_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf April. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf April"},{"key":"1763_CR43","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L. u. a. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf Juli. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inf Juli"},{"key":"1763_CR44","unstructured":"Paul T, Thiel A. Eating disorder inventory-2 (EDI-2): deutsche Version. 2005."},{"key":"1763_CR45","unstructured":"Franke G. Die Symptom-Checkliste von Derogatis (SCL-90-R) - Deutsche Version - Manual. 2002."},{"key":"1763_CR46","unstructured":"Wechsler DWIE. Wechsler-Intelligenztest f\u00fcr Erwachsene. Harcourt Test Services Frankfurt\/M; 2006."},{"key":"1763_CR47","first-page":"456S","volume-title":"HAWIK-IV; Manual","author":"F Petermann","year":"2010","unstructured":"Petermann F, Petermann U. HAWIK-IV; Manual. 3., erg. Aufl. ed. Bern: Huber [u.a.]; 2010. p. 456S. Herausgeber Hamburg-Wechsler-Intelligenztest f\u00fcr Kinder - IV.","edition":"3"},{"issue":"17","key":"1763_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1055\/s-0030-1253666","volume":"135","author":"C Hemmelmann","year":"2010","unstructured":"Hemmelmann C, Brose S, Vens M, Hebebrand J, Ziegler A. Perzentilen des Body-Mass-Index auch f\u00fcr 18- bis 80-J\u00e4hrige? Daten der Nationalen Verzehrsstudie II. DMW - Dtsch Med Wochenschr April. 2010;135(17):848\u201352. https:\/\/doi.org\/10.1055\/s-0030-1253666.","journal-title":"DMW - Dtsch Med Wochenschr April"},{"issue":"8","key":"1763_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001120170107","volume":"149","author":"K Kromeyer-Hauschild","year":"2001","unstructured":"Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Gei\u00df HC, Hesse V. u. a. Perzentile f\u00fcr den Body-mass-Index f\u00fcr das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd August. 2001;149(8):807\u201318. https:\/\/doi.org\/10.1007\/s001120170107.","journal-title":"Monatsschr Kinderheilkd August"},{"key":"1763_CR50","unstructured":"JASP Team J. JASP. 2024, Version 0.18.3"},{"issue":"1","key":"1763_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol Januar. 1995;57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Stat Soc Ser B Methodol Januar"},{"key":"1763_CR52","doi-asserted-by":"publisher","unstructured":"Ruppert D. Trimming and Winsorization. In: Kenett RS, Longford NT, Piegorsch WW, Ruggeri F, Herausgeber. Wiley StatsRef: Statistics Reference Online [Internet]. 1. Aufl. Wiley; 2014 [zitiert 19. Juni 2024]. Verf\u00fcgbar unter: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/9781118445112.stat01887\u00a0","DOI":"10.1002\/9781118445112.stat01887"},{"issue":"5","key":"1763_CR53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1203\/00006450-200005000-00012","volume":"47","author":"RA Heptulla","year":"2000","unstructured":"Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Yong-Zhan. MA, u. a. Augmentation of Alimentary Insulin Secretion despite Similar Gastric Inhibitory Peptide (GIP) Responses in Juvenile Obesity. Pediatr Res Mai. 2000;47(5):628\u201333. https:\/\/doi.org\/10.1203\/00006450-200005000-00012.","journal-title":"Pediatr Res Mai"},{"issue":"10","key":"1763_CR54","doi-asserted-by":"publisher","first-page":"950","DOI":"10.2337\/diab.33.10.950","volume":"33","author":"D Elahi","year":"1984","unstructured":"Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R. The Enteric Enhancement of Glucose-stimulated Insulin Release: The Role of GIP in Aging, Obesity, and Non-insulin-dependent Diabetes Mellitus. Diabetes 1 Oktober. 1984;33(10):950\u20137. https:\/\/doi.org\/10.2337\/diab.33.10.950.","journal-title":"Diabetes 1 Oktober"},{"issue":"3","key":"1763_CR55","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/jc.2015-3885","volume":"101","author":"H Manell","year":"2016","unstructured":"Manell H, Staaf J, Manukyan L, Kristinsson H, Cen J, Stenlid R. u. a. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes. J Clin Endocrinol Metab 1 M\u00e4rz. 2016;101(3):1181\u20139. https:\/\/doi.org\/10.1210\/jc.2015-3885.","journal-title":"J Clin Endocrinol Metab 1 M\u00e4rz"},{"issue":"6","key":"1763_CR56","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1210\/clinem\/dgab098","volume":"106","author":"SE Stinson","year":"2021","unstructured":"Stinson SE, Jonsson AE, Lund MAV, Frithioff-B\u00f8js\u00f8e C, Aas Holm L, Pedersen O. u. a. Fasting Plasma GLP-1 Is Associated With Overweight\/Obesity and Cardiometabolic Risk Factors in Children and Adolescents. J Clin Endocrinol Metab 13 Mai. 2021;106(6):1718\u201327. https:\/\/doi.org\/10.1210\/clinem\/dgab098.","journal-title":"J Clin Endocrinol Metab 13 Mai"},{"issue":"1","key":"1763_CR57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","volume":"89","author":"JR Greenfield","year":"2009","unstructured":"Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A. u. a. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr Januar. 2009;89(1):106\u201313. https:\/\/doi.org\/10.3945\/ajcn.2008.26362.","journal-title":"Am J Clin Nutr Januar"},{"issue":"2","key":"1763_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2004-814222","volume":"36","author":"R Lugari","year":"2004","unstructured":"Lugari R, Dei Cas A, Ugolotti D, Camellini C, Ganzerla A, Luciani A. u. a. Glucagon-like Peptide 1 (GLP-1) Secretion and Plasma Dipeptidyl Peptidase IV (DPP-IV) Activity in Morbidly Obese Patients Undergoing Biliopancreatic Diversion. Horm Metab Res Februar. 2004;36(2):111\u20135. https:\/\/doi.org\/10.1055\/s-2004-814222.","journal-title":"Horm Metab Res Februar"},{"issue":"2","key":"1763_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0004563217700172","volume":"55","author":"J Raffort","year":"2018","unstructured":"Raffort J, Pana\u00efa-Ferrari P, Lareyre F, Blois M, Bayer P, Staccini P. u. a. Decreased serum glicentin concentration in patients with severe and morbid obesity. Ann Clin Biochem Int J Lab Med M\u00e4rz. 2018;55(2):198\u2013204. https:\/\/doi.org\/10.1177\/0004563217700172.","journal-title":"Ann Clin Biochem Int J Lab Med M\u00e4rz"},{"issue":"2","key":"1763_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/JOE-19-0201","volume":"243","author":"JH Stern","year":"2019","unstructured":"Stern JH, Smith GI, Chen S, Unger RH, Klein S, Scherer PE. Obesity dysregulates fasting-induced changes in glucagon secretion. J Endocrinol November. 2019;243(2):149\u201360. https:\/\/doi.org\/10.1530\/JOE-19-0201.","journal-title":"J Endocrinol November"},{"issue":"6","key":"1763_CR61","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterol Mai. 2007;132(6):2131\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2007. 03.054 PubMed PMID: 17498508.","journal-title":"Gastroenterol Mai"},{"issue":"16","key":"1763_CR62","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/ijms20163905","volume":"20","author":"O Al-Massadi","year":"2019","unstructured":"Al-Massadi O, Fern\u00f8 J, Di\u00e9guez C, Nogueiras R, Qui\u00f1ones M. Glucagon Control on Food Intake and Energy Balance. Int J Mol Sci 11 August. 2019;20(16):3905. https:\/\/doi.org\/10.3390\/ijms20163905","journal-title":"Int J Mol Sci 11 August"},{"issue":"11","key":"1763_CR63","doi-asserted-by":"publisher","first-page":"107996","DOI":"10.1016\/j.isci.2023.107996","volume":"26","author":"C Tezenas du Montcel","year":"2023","unstructured":"Tezenas du Montcel C, Duriez P, Cao J, Lebrun N, Ramoz N, Viltart O. u. a. The role of dysregulated ghrelin\/LEAP-2 balance in anorexia nervosa. iScience 2023;26(11):107996. https:\/\/doi.org\/10.1016\/j.isci.2023.107996","journal-title":"iScience 17 November"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-026-01763-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-026-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-026-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:17:49Z","timestamp":1789049869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40337-026-01763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1186\/s40337-026-01763-y","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols received ethical approval by the local Ethics Committee at TU Dresden under the reference number EK 14012011. All participants (or if underage, their guardians) gave written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TK, CFR, MO, LCS, JAK, and SLD have nothing to declare. FIT and SE have received research grants from the \u201cMarga and Walter Boll-Stiftung\u201d and the B. Braun Stiftung. FIT has received funding from the Medical Faculty of the Technische Universit\u00e4t Dresden (\u201cHabilitation Funding for Women\u201d). VR has received payment for consulting and writing activities from Lilly, Novartis and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out clinical trials in cooperation with the Novartis, Shire and Otsuka companies. CMP has received consultancy or speaker fees from V\u00e4rdePartners, Compass Pathways, and UCB. NP reports consulting fees from Bayer Vital GmbH, support from attending meetings and\/or travel from Lilly and Novo Nordisk, speaker honoraria from Novo Nordisk, Lilly, APOGEPHA, GWT-TUD, Transmedac Innovations AG, Elbe-Gesundsheizszentrum GmbH, DACH, Intercom, honorarium as Guest Editor of Open Exploration and as Associate Editor of Elsevier outside the submitted work.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"217"}}